Recent Posts
- FDA Published Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products, and Devices
- FDA Published Patient-Focused Drug Development Guidance Document: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making
- FDA Publishes Guidance on a Risk-Based Approach to Monitoring Clinical Investigations
- ECA GMP Equipment Design Guide
- FDA Issued Guidance to Help Identify Suspect and Illegitimate Product in the U.S. Pharmaceutical Distribution Supply Chain